<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>APC/β-catenin pathway perturbation is a common early event in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and is affected by calcium and <z:chebi fb="27" ids="27300">vitamin D</z:chebi> in basic science studies </plain></SENT>
<SENT sid="1" pm="."><plain>To assess the effects of calcium and <z:chebi fb="27" ids="27300">vitamin D</z:chebi> on <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC), β-catenin, and E-cadherin expression in the <z:mpath ids='MPATH_458'>normal</z:mpath> appearing colorectal mucosa of <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> patients, we conducted a randomized, double-blinded, placebo-controlled 2 × 2 factorial clinical trial </plain></SENT>
<SENT sid="2" pm="."><plain>Pathology-confirmed colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> cases were treated with 2 g/day <z:chebi fb="0" ids="35155">elemental calcium</z:chebi> and/or 800 IU/day <z:chebi fb="27" ids="27300">vitamin D</z:chebi>(3) versus placebo over 6 months (N = 92; 23/group) </plain></SENT>
<SENT sid="3" pm="."><plain>Overall APC, β-catenin, and E-cadherin expression and distributions in colon crypts in <z:mpath ids='MPATH_458'>normal</z:mpath>-appearing rectal mucosa biopsies were detected by standardized automated immunohistochemistry and quantified by image analysis </plain></SENT>
<SENT sid="4" pm="."><plain>In the <z:chebi fb="27" ids="27300">vitamin D</z:chebi>(3)-supplemented group relative to placebo, the proportion of APC in the upper 40% of crypts (Φh APC) increased 21% (P = 0.01), β-catenin decreased 12% (P = 0.18), E-cadherin increased 72% (P = 0.03), and the Φh APC/β-catenin ratio (APC/β-catenin score) increased 31% (P = 0.02) </plain></SENT>
<SENT sid="5" pm="."><plain>In the calcium-supplemented group Φh APC increased 10% (P = 0.12), β-catenin decreased 15% (P = 0.08), and the APC/β-catenin score increased 41% (P = 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>In the calcium/<z:chebi fb="27" ids="27300">vitamin D</z:chebi>(3)-supplemented group, β-catenin decreased 11% (P = 0.20), E-cadherin increased 51% (P = 0.08), and the APC/β-catenin score increased 16% (P = 0.26) </plain></SENT>
<SENT sid="7" pm="."><plain>These results support (i) that calcium and <z:chebi fb="27" ids="27300">vitamin D</z:chebi> modify APC, β-catenin, and E-cadherin expression in humans in directions hypothesized to reduce risk for colorectal <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, (ii) calcium and <z:chebi fb="27" ids="27300">vitamin D</z:chebi> as potential chemopreventive agents against colorectal <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, and (iii) the potential of APC, β-catenin, and E-cadherin expression as modifiable, preneoplastic risk biomarkers for colorectal <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
</text></document>